Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The news anchor gets his first shot in the United States, phase 3

The news anchor gets his first shot in the United States, phase 3





a woman sitting in a chair talking on the phone: A screenshot of CNN's Elizabeth Cohen interviewing the first American contestant to receive a Moderna Phase 3 trial vaccine.


© CNN
A CNN screenshot of Elizabeth Cohen interviewing the first American contestant to receive a Moderna Phase 3 trial vaccine.

Dawn Baker was “a little nervous”

; but “really excited” on Monday when she made a story.

That morning, Baker, a news anchor at CNN’s WTOC branch in Savannah, Georgia, became the first volunteer to receive an injection in the first phase 3 clinical trial of a coronavirus vaccine in the United States.

The many lives lost and affected by the coronavirus pandemic inspired Baker to volunteer.

“It’s really empowering for me that I could be this person who could help save some lives. It was very heartbreaking to hear about people who lost their lives because of it,” Baker told the senior medical officer. CNN correspondent Elizabeth Cohen on the Meridian Clinical Research website in Savannah on Monday.

According to cases in the United States at Johns Hopkins University, there are more than 4.2 million confirmed cases of coronavirus in the United States and at least 146,935 people have died.

“I never thought I would do something like that,” Baker said. “I hope they are really, really good results. I know a lot of people do a lot of different vaccine tests.”

The competition for a vaccine against Covid-19 continues around the world. Globally, at least 25 candidates for the Covid-19 vaccine are being tested on humans, according to the World Health Organization. Five of them are in phase 3 trials, the most advanced stage of testing before the vaccine is released.

Creating a story

The Covid-19 vaccine, which is being tested in a Phase 3 trial in the United States, was developed by the biotechnology company Moderna and the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The test is to be conducted at 89 research sites in the United States, according to NIAID.

This is “the fastest time the virus, a pathogen, has been identified until it actually enters a phase 3 trial, literally in the history of vaccinology in the United States at least, and perhaps even worldwide,” NIAID This was said by Dr. Anthony Fawsi during a live NIH Facebook event on Monday.

The phase 3 trial is expected to involve approximately 30,000 adult volunteers to assess whether the Modern / NIH vaccine can safely prevent symptomatic Covid-19 after two doses, among other results. Volunteers will receive either two injections of 100 micrograms of the vaccine or a placebo about 28 days apart. Researchers and participants will not know who received the vaccine.

Baker was not told if she had received the vaccine or a placebo. Just minutes after he shot her, Baker told CNN’s Cohen that “it’s painless” and more before she even realized it.

While on the research site in Savannah, Baker thought about his colleague Lindsay Goff – who is among those affected by the coronavirus.

Gough, a reporter for the WTOC news station, went from reporting coronavirus to testing positive for Covid-19 in late June. Goff, 27, spent 11 days in hospital battling the disease.

“It really just broke my heart because she’s such a young, strong, energetic young lady who’s just passionate about what she’s doing, and to see her after that, she was so weak and also knew what could happen to her. “She lost her appendix because of Kovid,” Baker said, adding that Guf was now home.

“We are all responsible for fulfilling our role”

Monday was not the first time Baker had volunteered for a medical cause.

Baker is involved in a medical mission to Ghana with the Kindness and Mercy Foundation, according to her biography on the WTOC website. She returned from this mission in June 2006. Then the following year, in February 2007, she participated in a medical mission in Guatemala with a group called Faith In Practice. A few months later in September, she spent a week at the Foundation for Goodness and Mercy in Ajali, Nigeria.

“I believe we are all responsible for doing our part to improve the quality of life of our neighbor,” Baker wrote in his biography.

Now, Baker is not only making history as the first volunteer to receive a shot in the Phase 3 process, but also as a Black Woman volunteer involved in the process.

Black and brown communities were disproportionately affected by the coronavirus pandemic. Doctors work to get a racially diverse group of volunteers involved in vaccine research.

“African Americans have a history – for good reason – of worrying about medicine. In the past, we’ve been subjected to all sorts of experiments where we didn’t know what was going on,” Baker said. For example, in the infamous Tuskji experiment, black men were tested for syphilis without their consent and were not offered penicillin to treat their disease.

“I’ve heard a lot of my friends and even relatives say you know, ‘I’m not going to be the first person to get this vaccine.’ I don’t want to be a guinea pig. I’ll go wait and see what happens first. So they are very suspicious. So maybe, because I was brave enough to move forward right now, it could change that – it could save their lives in the end, “Baker said.” I hope maybe just seeing my face will help them change their minds about it. “

Video: Here’s what Fauci thinks about the latest vaccine trial (CNN)



Source link